ScreenerHero

IBAB Ion Beam Applications SA

EBR · BE · Healthcare · Medical Devices · iba-worldwide.com
15.22EUR+0.40%Mkt Cap: 480.43M $P/E: 18.56

Ion Beam Applications SA designs, produces, and markets solutions for cancer diagnosis and treatments, serious illnesses, and industrial applications in Belgium, the United States, China, Germany, and India. It operates …

Industry Peers

Medical Devices
Screen all
ABT
Abbott Laboratories
$174.36BUSDP/E 32.3
MDT
Medtronic plc
$112.53BUSDP/E 21.6
SYK
Stryker Corporation
$109.40BUSDP/E 29.6
BSX
Boston Scientific Corporation
$61.45BUSDP/E 17.2
EW
Edwards Lifesciences Corporation
$50.23BUSDP/E 51.9
SHL
Siemens Healthineers AG
$46.06BUSDP/E 19.2
DXCM
DexCom, Inc.
$32.79BUSDP/E 34.5
GEHC
GE HealthCare Technologies Inc.
$29.90BUSDP/E 15.1
PHG
Koninklijke Philips N.V.
$23.37BUSDP/E 17.8
PHIA
Koninklijke Philips N.V.
$22.58BUSDP/E 18.5
STE
STERIS plc
$20.58BUSDP/E 25.8
SOON
Sonova Holding AG
$17.06BUSDP/E 27.9
ZBH
Zimmer Biomet Holdings, Inc.
$17.47BUSDP/E 22.2
TXG
10x Genomics, Inc.
$12.73BUSD
PEN
Penumbra, Inc.
$12.49BUSDP/E 77.9
SNN
Smith & Nephew plc
$11.27BUSDP/E 18.3
GMED
Globus Medical, Inc.
$10.28BUSDP/E 19.6
BIO
Bio-Rad Laboratories, Inc.
$10.16BUSDP/E 48.1
DEMANT
Demant A/S
$9.81BUSDP/E 27.8
BRKR
Bruker Corporation
$9.73BUSD

Key Statistics

Company
Market Cap480.43M USD
Enterprise Value565.81M USD
Revenue (TTM)694.57M USD
Gross Profit216.97M USD
Net Income (TTM)13.84M USD
Revenue/Share21.76 EUR
Last Price15.22 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees2.3K
CountryBE
SectorHealthcare
IndustryMedical Devices
ISINBE0003766806
Valuation
P/E (Trailing)18.56
P/E (Forward)13.72
PEG—
EV/EBITDA11.15
EV/Revenue0.81
P/S0.69
P/B3.74
EPS (TTM)0.82
EPS (Forward)1.10
52W Range
9.90068% of range17.76
52W High17.76 EUR
52W Low9.900 EUR
Profitability
Gross Margin32.19%
Oper. Margin3.98%
EBITDA Margin7.30%
Profit Margin2.05%
ROE10.01%
ROA1.84%
Growth
Revenue Growth6.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-27.90M USD
CapEx (TTM)13.81M USD
FCF Margin2.50%
FCF Yield3.61%
Net Debt81.49M USD
Net Debt/EBITDA1.61
Balance Sheet
Debt/Equity0.92
Current Ratio0.99
Quick Ratio0.58
Book Value/Sh4.06 EUR
Cash/Share1.49 EUR
Dividends
Fwd Div Rate0.25 EUR
Trail. Div Rate0.25 EUR
Div. Yield1.65%
5Y Avg Yield1.45%
Payout Ratio30.67%
Ex-Div DateJun 15, 2026
Pay Date—
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)17.63 EUR
Upside (mean)+15.8%
Target Range12.00 EUR – 20.50 EUR
12.00+15.8% to mean20.50
# Analysts4
Ownership
Shares Out.29.04M
Float27.21M
Insiders36.61%
Institutions21.16%
Technical
SMA 5015.73 (-3.3%)
SMA 20015.16 (+0.4%)
Beta1.22
S&P 52W Chg14.58%
Avg Vol (30d)19.85K
Avg Vol (10d)15.55K
Technical Indicators
RSI (14)43.1
MACD-0.1119
MACD Signal-0.1224
MACD Hist.+0.0105
BB Upper15.69 EUR
BB Middle15.37 EUR
BB Lower15.04 EUR
BB Width4.23%
ATR (14)0.3821 EUR
Vol Ratio (20d)0.79x